Accelerate Diagnostics Inc (AXDX)
1.64
-0.03
(-1.80%)
USD |
NASDAQ |
Nov 22, 16:00
1.65
+0.01
(+0.61%)
After-Hours: 20:00
Accelerate Diagnostics Revenue (Quarterly): 2.975M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.975M |
| June 30, 2024 | 2.986M |
| March 31, 2024 | 2.921M |
| December 31, 2023 | 3.027M |
| September 30, 2023 | 3.299M |
| June 30, 2023 | 2.921M |
| March 31, 2023 | 2.812M |
| December 31, 2022 | 2.972M |
| September 30, 2022 | 2.96M |
| June 30, 2022 | 3.861M |
| March 31, 2022 | 2.958M |
| December 31, 2021 | 3.343M |
| September 30, 2021 | 3.122M |
| June 30, 2021 | 2.798M |
| March 31, 2021 | 2.518M |
| December 31, 2020 | 3.109M |
| September 30, 2020 | 3.588M |
| June 30, 2020 | 2.125M |
| March 31, 2020 | 2.342M |
| December 31, 2019 | 3.47M |
| September 30, 2019 | 2.271M |
| June 30, 2019 | 1.806M |
| March 31, 2019 | 1.75M |
| December 31, 2018 | 1.822M |
| September 30, 2018 | 1.355M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.692M |
| March 31, 2018 | 0.801M |
| December 31, 2017 | 2.119M |
| September 30, 2017 | 0.828M |
| June 30, 2017 | 0.699M |
| March 31, 2017 | 0.53M |
| December 31, 2016 | 0.039M |
| September 30, 2016 | 0.024M |
| June 30, 2016 | 0.02M |
| March 31, 2016 | 0.163M |
| December 31, 2015 | 0.022M |
| September 30, 2015 | 0.092M |
| June 30, 2015 | 0.019M |
| March 31, 2015 | 0.014M |
| December 31, 2014 | 0.079M |
| September 30, 2014 | 0.016M |
| June 30, 2014 | 0.013M |
| March 31, 2014 | 0.014M |
| December 31, 2013 | 0.012M |
| September 30, 2013 | 0.013M |
| June 30, 2013 | 0.007M |
| March 31, 2013 | 0.016M |
| October 31, 2012 | 0.0083M |
| July 31, 2012 | 0.0125M |
| April 30, 2012 | 0.0132M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.125M
Minimum
Jun 2020
3.861M
Maximum
Jun 2022
3.005M
Average
2.974M
Median
Revenue (Quarterly) Benchmarks
| Bruker Corp | 864.40M |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 14.67M |
| Xtant Medical Holdings Inc | 27.94M |
| Senseonics Holdings Inc | 4.263M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.64M |
| Total Expenses (Quarterly) | 11.59M |
| EPS Diluted (Quarterly) | -0.59 |
| Enterprise Value | 78.16M |
| Gross Profit Margin (Quarterly) | 28.77% |
| Profit Margin (Quarterly) | -492.1% |
| Earnings Yield | -161.0% |
| Normalized Earnings Yield | -157.87 |